1-6 of 6
Anthea Peters, MSc, MD FRCPC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada

Free
Robert Puckrin, MD, Haidar El Darsa, MD, Sunita Ghosh, PhD P Stat, Anthea Peters, MSc, MD FRCPC, Douglas A. Stewart, MD FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-139025
Published: 2020
Journal Articles

Epidemiology of Post-Transplant Lymphoproliferative Disorders in Children with Solid Organ Transplant over 34 Years of a Single Center Experience

Free
Marta Rojas Vasquez, MD FRCPC, Anthea Peters, MSc, MD FRCPC, Raymond Lai, MD PhD FRCP, Curtis Mabilangan, MSc, Burton Catherine, MD FRCPC, Jutta Preiksaitis, MDFRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 1602.
https://doi.org/10.1182/blood-2019-125344
Published: 2019
Journal Articles

Autologous Transplantation Improves Survival Rates for Follicular Lymphoma Patients Who Relapse within 2-Years of Chemoimmunotherapy: A Multi-Centre Retrospective Analysis of Consecutively Treated Patients in the Real World

Free
Mita Manna, MD FRCPC, Richard Lee-Ying, MD FRCPC, Gwynivere Davies, MDFRCPC, Anthea Peters, MSc, MD FRCPC, Danielle Oh, MD, Colin Stewart, Douglas A. Stewart
Journal: Blood
Blood (2017) 130 (Supplement 1): 3298.
https://doi.org/10.1182/blood.V130.Suppl_1.3298.3298
Published: 2017
Journal Articles

Monomorphic Post Transplant Lymphoproliferative Disorder (Diffuse Large B Cell Lymphoma subtype) Successfully Treated without Chemotherapy after Solid Organ Transplant in Children

Free
Marta Rojas Vasquez, MD FRCPC, Sunil J. Desai, MRCP, FRCPC, BM, BCh, Anthea Peters, MSc, MD FRCPC, Simon Urschel, MDFAKJ, Jason Yap, MDFRCPC, Raymond Lai, PhD MD, Catherine Morgan, MDFRCPC, Jutta Preiksaitis, MDFRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 1579.
https://doi.org/10.1182/blood.V130.Suppl_1.1579.1579
Published: 2017
Journal Articles

A Phase II Clinical Trial of the Pan PI3K Inhibitor, Buparlisib, for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia: Canadian Cancer Trials Group IND.216

Free
Sarit Assouline, MD, Lilian Amrein, PhD, Versha Banerji, MD FRCP, Stephen Caplan, MD, Carolyn Jane Owen, MD FRCPC, Wanda Hasegawa, MD, Sue Robinson, MD, Sudeep Shavikumar, MD, Anca Prica, MD FRCP(C), Anthea Peters, MSc, MD FRCPC, Linda Hagerman, Laura Rodriguez, Tanya Skamene, MD, Lawrence Panasci, MD, Bingshu E. Chen, Annette E Hay
Journal: Blood
Blood (2017) 130 (Supplement 1): 4319.
https://doi.org/10.1182/blood.V130.Suppl_1.4319.4319
Published: 2017
Journal Articles

Significant Adverse Consequences of Initial Watchful Waiting for Follicular Lymphoma Patients: A Retrospective Analysis of Patients Diagnosed in Alberta from 1994-2011

Free
Gwynivere Davies, MDFRCPC, Sunita Ghosh, PhD P Stat, Danielle Oh, MD, Mita Manna, MD FRCPC, Anthea Peters, MSc, MD FRCPC, Colin Stewart, Douglas A. Stewart
Journal: Blood
Blood (2017) 130 (Supplement 1): 4041.
https://doi.org/10.1182/blood.V130.Suppl_1.4041.4041
Published: 2017